Guidelines

Pediatric migraine prevention guideline focuses on lifestyle choices

October 17, 2019
Pharmacologic treatments to prevent migraine in children and teens are effective, but so is placebo, complicating the issue for clinicians and…

In the Journals

Brain injury from concussion can last a year after returning to play

October 16, 2019
Athletes may not be fully recovered from a concussion 1 year after being cleared to return to play, according to a study published in Neurology

In the Journals

Nonpharmacological dementia interventions may be more effective in reducing aggression, agitation

October 15, 2019
Nonpharmacologic interventions, including massage and touch therapy, may be more effective than pharmacologic methods in reducing aggression and…

FDA News

Reyvow approved for acute migraine treatment

October 11, 2019
The FDA announced it approved Reyvow for the treatment of adults with acute migraine with or without aura. According to a press release from the…

In the Journals

Only one in five adult cyclists in accidents wear helmets

October 9, 2019
Just 22% of adults involved in bicycle accidents were wearing helmets, according to study results published in Brain Injury. Shahrzad

In the JournalsPerspective

Donepezil carries higher hospitalization risk than other Alzheimer’s drugs

October 2, 2019
Older patients prescribed donepezil had a higher risk for hospital admission for rhabdomyolysis than patients prescribed rivastigmine or galantamine…

In the Journals

Telehealth improves quality of life for dementia patients, caregivers

September 30, 2019
The quality of life of patients with dementia and their caregivers can be improved through a collaborative telehealth care intervention that provides…

Meeting News

Reconsidering, retiring the controversial ‘lupus headache’

September 28, 2019
SAN DIEGO — Although “lupus headache” remains a disease-related entity in the Systemic Lupus Erythematosus Disease Activity Index…

In the Journals

Amount of alcohol consumed tied to dementia risk in older adults

September 27, 2019
The amount of alcohol older adults consume affects their risk for dementia differently depending on whether they have mild cognitive impairment…

Meeting News

Mobile games may help infer cognitive performance

September 27, 2019
Swipe speed and length during mobile game play were linked to cognitive performance in visual search, mental flexibility and response inhibition…

In the Journals

Research continues for disease-modifying therapy in Alzheimer’s disease

September 24, 2019
Following the discontinuation of a phase 3 trial of aducanumab, an anti-amyloid compound that showed potential as a disease-modifying therapy, or…

Feature

Risk for neural tube defects from dolutegravir lower than previously thought

Infectious Diseases in Children, September 2019
According to results from the ongoing Tsepamo study in Botswana, infants born to women who took the integrase inhibitor dolutegravir for HIV…

In the Journals

Exercise benefits neuropsychological function in individuals with MCI

September 19, 2019
Participation in an aerobic exercise training or a stretching and toning program was linked to improved performance on memory and executive function…

Meeting News

Ponesimod more effective than existing treatment for relapsing MS, study finds

September 13, 2019
Ponesimod, an investigational selective S1P1 receptor modulator, was more effective at treating adults with relapsing multiple sclerosis than…

Top articles for World Alzheimer’s Month

September 11, 2019
Within the next 30 years, the number of people with dementia is set to triple, according to WHO. About 50 million people have dementia worldwide…

Guidelines

USPSTF: Insufficient evidence to screen asymptomatic older adults for cognitive impairment

September 10, 2019
The U.S. Preventive Services Task Force recently concluded that the evidence is insufficient to recommend screening for cognitive impairment in…

Meeting News

Effient superior to Brilinta in patients with acute coronary syndrome

September 9, 2019
The rate of death, myocardial infarction or stroke was significantly reduced at 1 year with Effient compared with Brilinta in patients with acute…

In the Journals

Migraine significant risk factor for Alzheimer’s disease

September 5, 2019
A history of migraine was a significant risk factor for Alzheimer's disease and for all-cause dementia, but not vascular dementia, according to a…

In the Journals

Pradaxa safe, effective for recurrent VTE prevention

September 3, 2019
Warfarin and Pradaxa were both safe and effective at preventing recurrent venous thrombotic events in patients with cerebral venous thrombosis…

In the Journals

LMNA gene mutation linked to neuromuscular, cardiac conditions in most patients

September 3, 2019
Patients with LMNA gene mutations are likely to develop life-threatening neuromuscular or cardiac conditions, according to study results published…